RHO(D) IMMUNE GLOBULIN

Course overview

RHO(D) IMMUNE GLOBULIN (RHIG) IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF RH-NEGATIVE PREGNANCIES AND IMMUNE THROMBOCYTOPENIC PURPURA. IT IS IN THE IMMUNE GLOBULIN BIOLOGICAL CLASS OF DRUGS. THIS ACTIVITY REVIEWS THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR RHIG AS A VALUABLE AGENT IN THE MANAGEMENT RHIG IN PREVENTING HEMOLYTIC DISEASE OF THE NEWBORN AND IMMUNE THROMBOCYTOPENIC PURPURA AND OTHER DISORDERS WHEN APPLICABLE. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE HEALTHCARE TEAM IN MANAGING PATIENTS WITH RH-NEGATIVE PREGNANCIES, IMMUNE THROMBOCYTOPENIC PURPURA, AND RELATED CONDITIONS.